References
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA. Cancer. J. Clin. 2011;61(2):69-90. https://doi.org/10.3322/caac.20107
- Loblaw A, et al. Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes. Radiother. Oncol. 2013;107(2):153-158. https://doi.org/10.1016/j.radonc.2013.03.022
- Sahgal A, et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin. Oncol. 2012;24(9):629-639. https://doi.org/10.1016/j.clon.2012.04.006
- Ritter M. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin. Radiat. Oncol. 2008;18(4):249-256. https://doi.org/10.1016/j.semradonc.2008.04.007
- Brenner DJ, Hall EJ. Hypofractionation in prostate cancer radiotherapy. Transl. Cancer. Res. 2018;7(6):S632-S639. https://doi.org/10.21037/tcr.2018.01.30
- Oliai C, et al. Stereotactic body radiation therapy for the primary treatment of localized prostate cancer. J. Radiat. Oncol. 2013;2(1):63-70. https://doi.org/10.1007/s13566-012-0067-2
- Lischalk JW, Kaplan ID, Collins SP. Stereotactic body radiation therapy for localized prostate cancer. Cancer. J. 2016;22(4):307-313. https://doi.org/10.1097/PPO.0000000000000209
- Henderson D, Tree A, Van As N. Stereotactic body radiotherapy for prostate cancer. Clin. Oncol. 2015;27(5):270-279. https://doi.org/10.1016/j.clon.2015.01.011
- Musunuru HB, Quon H, Davidson M, Cheung P, Zhang L, D'Alimonte L, Deabreu A, Mamedov A, Loblaw A. Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials. Radiother. Oncol. 2016;118(1):112-117. https://doi.org/10.1016/j.radonc.2015.12.020
- Folkert MR, Timmerman RD. Stereotactic ablative body radiosurgery (SABR) or stereotactic body radiation therapy (SBRT). Adv. Drug. Del. Rev. 2017;109(15):3-14. https://doi.org/10.1016/j.addr.2016.11.005
- Mutic S, Dempsey JF. The ViewRay system: Magnetic resonanceguided and controlled radiotherapy. Semin. Radiat. Oncol. 2014;24(3):196-199. https://doi.org/10.1016/j.semradonc.2014.02.008
- Saenz DL, Paliwal BR, Bayouth JE. A dose homogeneity and conformity evaluation between ViewRay and pinnacle-based linear accelerator IMRT treatment plans. J. Med. Phys. 2014;39(2):64-70. https://doi.org/10.4103/0971-6203.131277
- Wooten HO, Rodriguez V, Green O, Kashani R, Santanam L, Tanderup K, Mutic S, Li HH. Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system. Radiother. Oncol. 2015;114(3):402-405. https://doi.org/10.1016/j.radonc.2015.01.015
- Kirkby C, Stanescu T, Rathee S, Carlone M, Murray B, Fallone B. Patient dosimetry for hybrid MRI‐radiotherapy systems. Med. Phys. 2008;35(3):1019-1027. https://doi.org/10.1118/1.2839104
- Bol G, Lagendijk J, Raaymakers B. Compensating for the impact of non-stationary spherical air cavities on IMRT dose delivery in transverse magnetic fields. Phys. Med. Biol. 2015;60(2):755-768. https://doi.org/10.1088/0031-9155/60/2/755
- Raaijmakers A, Raaymakers BW, Lagendijk JJ. Magnetic-fieldinduced dose effects in MR-guided radiotherapy systems: dependence on the magnetic field strength. Phys. Med. Biol. 2008;53(4):909-923. https://doi.org/10.1088/0031-9155/53/4/006
- Esmaeeli A, Pouladian M, Monfared A, Mahdavi S, Moslemi D. Effect of uniform magnetic field on dose distribution in the breast radiotherapy. Int. J. Radiat. Res. 2014;12(2):161-170.
- Kim JI, Park SY, Lee YH, Shin KH, Wu HG, Park JM. Effect of low magnetic field on dose distribution in the partial-breast irradiation. Prog. Med. Phys. 2015;26(4):208-214. https://doi.org/10.14316/pmp.2015.26.4.208
- Son J, Chun M, An HJ, Kang SH, Chie EK, Yoon J, Choi CH, Park JM, Kim JI. Effect of low magnetic field on dose distribution in the SABR plans for liver cancer. Prog. Med. Phys. 2018;29(2):47-52. https://doi.org/10.14316/pmp.2018.29.2.47
Cited by
- Electron streams in air during magnetic-resonance image-guided radiation therapy vol.14, pp.5, 2019, https://doi.org/10.1371/journal.pone.0216965